Cargando…

Real World Cost-Effectiveness Analysis of Population Screening for BRCA Variants among Ashkenazi Jews Compared with Family History-Based Strategies

SIMPLE SUMMARY: Identifying BRCA mutations carriers reduces cancer incidence by surveillance and prevention. We analyzed the cost-effectiveness of population screening (PS) for BRCA mutations in Ashkenazi Jews (AJ), for whom carrier rate is 2.5%, compared with existing strategies: cascade testing (C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michaelson-Cohen, Rachel, Cohen, Matan J., Cohen, Carmit, Greenberg, Dan, Shmueli, Amir, Lieberman, Sari, Tomer, Ariela, Levy-Lahad, Ephrat, Lahad, Amnon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776581/ https://www.ncbi.nlm.nih.gov/pubmed/36551598 http://dx.doi.org/10.3390/cancers14246113

Ejemplares similares

Prenatal Isolated Ventricular Septal Defect May Not Be Associated with Trisomy 21
por: Shen, Ori, et al.
Publicado: (2014)

Population‐based screening of Uruguayan Ashkenazi Jews for recurrent BRCA1 and BRCA2 pathogenic sequence variants
por: Castillo, Cecilia, et al.
Publicado: (2022)

Genetic contribution to multiple sclerosis risk among Ashkenazi Jews
por: Khankhanian, Pouya, et al.
Publicado: (2015)

An identical novel mutation in BRCA1 and a common haplotype in familial ovarian cancer in non-Ashkenazi Jews.
por: Theodor, L., et al.
Publicado: (1998)

Randomised trial of population‐based BRCA testing in Ashkenazi Jews: long‐term secondary lifestyle behavioural outcomes
por: Burnell, Matthew, et al.
Publicado: (2022)

Cancer risks among BRCA1 and BRCA2 mutation carriers
por: Levy-Lahad, E, et al.
Publicado: (2007)

Analysis of genetic variation in Ashkenazi Jews by high density SNP genotyping
por: Olshen, Adam B, et al.
Publicado: (2008)

Physician-facilitated designation of proxy decision-makers: family physician perceptions
por: Lifshitz, Gideon, et al.
Publicado: (2016)

Revisiting the prevalence of nonclassic congenital adrenal hyperplasia in US Ashkenazi Jews and Caucasians
por: Hannah-Shmouni, Fady, et al.
Publicado: (2017)

The Effect of GBA Mutations and APOE Polymorphisms on Dementia with Lewy Bodies in Ashkenazi Jews
por: Shiner, Tamara, et al.
Publicado: (2021)

Vrk1 partial Knockdown in Mice Results in Reduced Brain Weight and Mild Motor Dysfunction, and Indicates Neuronal VRK1 Target Pathways
por: Vinograd-Byk, Hadar, et al.
Publicado: (2018)

Pitfalls of the Geographic Population Structure (GPS) Approach Applied to Human Genetic History: A Case Study of Ashkenazi Jews
por: Flegontov, Pavel, et al.
Publicado: (2016)

Pitfalls of the Geographic Population Structure (GPS) Approach Applied to Human Genetic History: A Case Study of Ashkenazi Jews
Publicado: (2017)

A founder deletion in the TRPM1 gene associated with congenital stationary night blindness and myopia is highly prevalent in Ashkenazi Jews
por: Hirsch, Yoel, et al.
Publicado: (2019)

TODRA, a lncRNA at the RAD51 Locus, Is Oppositely Regulated to RAD51, and Enhances RAD51-Dependent DSB (Double Strand Break) Repair
por: Gazy, Inbal, et al.
Publicado: (2015)

A genetic contribution from the Far East into Ashkenazi Jews via the ancient Silk Road
por: Tian, Jiao-Yang, et al.
Publicado: (2015)

Israeli Position Paper: Triage Decisions for Severely Ill Patients During the COVID-19 Pandemic
por: Steinberg, Avraham, et al.
Publicado: (2020)

Variable Features of Juvenile Polyposis Syndrome With Gastric Involvement Among Patients With a Large Genomic Deletion of BMPR1A
por: Lieberman, Sari, et al.
Publicado: (2019)

Evaluation of genetic alterations in hereditary cancer susceptibility genes in the Ashkenazi Jewish women community of Mexico
por: Díaz-Velásquez, Clara Estela, et al.
Publicado: (2023)

Snord 3A: A Molecular Marker and Modulator of Prion Disease Progression
por: Cohen, Eran, et al.
Publicado: (2013)

Increased rate of sporadic and recurrent rare genic copy number variants in Parkinson's disease among Ashkenazi Jews
por: Liu, Xinmin, et al.
Publicado: (2013)

Recent Selection on a Class I ADH Locus Distinguishes Southwest Asian Populations Including Ashkenazi Jews
por: Gu, Sheng, et al.
Publicado: (2018)

Variant Tyr 394Ser in the GCM2 Gene Is Rare in a Cohort of Ashkenazi Jews With Primary Hyperparathyroidism
por: Tolkin, Lior, et al.
Publicado: (2023)

The Jews in the world of the Renaissance
Publicado: (1978)

Israeli Position Paper: Triage Decisions for Severely Ill Patients During the COVID-19 Pandemic. Joint Commission of the Israel National Bioethics Council, the Ethics Bureau of the Israel Medical Association and Representatives from the Israeli Ministry of Health
por: Steinberg, Avraham, et al.
Publicado: (2020)

Establishment of Homozygote Mutant Human Embryonic Stem Cells by Parthenogenesis
por: Epsztejn-Litman, Silvina, et al.
Publicado: (2015)

Genome-wide data from medieval German Jews show that the Ashkenazi founder event pre-dated the 14(th) century
por: Waldman, Shamam, et al.
Publicado: (2022)

Medicine and the German Jews: a history
por: Weindling, Paul
Publicado: (2003)

VRK1 regulates Cajal body dynamics and protects coilin from proteasomal degradation in cell cycle
por: Cantarero, Lara, et al.
Publicado: (2015)

Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History–Based Testing
por: Manchanda, Ranjit, et al.
Publicado: (2014)

Prevalence of Germline BRCA1/2 Variants in Ashkenazi and Non-Ashkenazi Prostate Cancer Populations: A Systematic Review and Meta-Analysis
por: Cioffi, Antonio, et al.
Publicado: (2023)

Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA)
por: Apicella, Carmel, et al.
Publicado: (2003)

Clinical testing of BRCA1 and BRCA2: a worldwide snapshot of technological practices
por: Toland, Amanda Ewart, et al.
Publicado: (2018)

Analysis of the genetic basis of height in large Jewish nuclear families
por: Zeevi, Danny, et al.
Publicado: (2019)

The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients
por: Chen-Shtoyerman, R, et al.
Publicado: (2001)

The genetic history of Cochin Jews from India
por: Waldman, Yedael Y., et al.
Publicado: (2016)

Case report: BRCA in the Ashkenazi population: are current testing guidelines too exclusive?
por: Saunders, Katherine H, et al.
Publicado: (2011)

The time and place of European admixture in Ashkenazi Jewish history
por: Xue, James, et al.
Publicado: (2017)

The landscape of medical care consumption in Israel: a nationwide population cross-sectional study
por: Yosef, Yoni, et al.
Publicado: (2022)

The case for orthopaedic medicine in Israel
por: Finestone, Aharon S, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vdrf33q1ac7084bcesqq02pelr